Immunology
173.7K views | +19 today
Follow
Immunology
Teaching and Learning Immunology. Information you never would have searched for!
Your new post is loading...
Your new post is loading...
Rescooped by Gilbert C FAURE from Cancer Immunotherapy Review and Collection
Scoop.it!

Manipulating IL-10 signalling blockade for better immunotherapy

Manipulating IL-10 signalling blockade for better immunotherapy | Immunology | Scoop.it

Abstract

Interleukin 10 is a cytokine with the ability to reduce or terminate inflammation. Chronic viral infection, such as infection of chronic hepatitis B, hepatitis C and HIV, has increased levels of interleukin 10 in peripheral blood. Serum IL-10 levels are also high in certain cancers. Blocking IL-10 signalling at the time of immunisation clears chronic viral infection and prevents tumour growth in animal models. We review recent advances in this area, with the emphasis on potential use of this novel strategy to treat chronic viral infection and cancer in human.


Via Krishan Maggon
Krishan Maggon 's curator insight, January 20, 2015 3:47 AM
Highlights

 

IL-10 signalling blockade at the time of immunisation clear chronic viral infection.

IL-10 signalling can inhibit or promote tumour growth.

IL-10 signalling inhibitors are under development.

Potential side effects of IL-10 signalling blockade.

Scooped by Gilbert C FAURE
Scoop.it!

Interleukin-10 receptor-1 expression in monocyte-derived antigen-pr... - PubMed - NCBI

Genes Immun. 2014 Dec 4. doi: 10.1038/gene.2014.69. [Epub ahead of print]
Gilbert C FAURE's insight:

Interleukin (IL)-10 is an important immunoregulatory cytokine that mediates its effects via a transmembrane receptor complex consisting of two different chains, IL-10R1 and IL-10R2. While IL-10R2 is ubiquitously expressed and does not bind IL-10 primarily, the expression of IL-10R1 determines cellular responsiveness. However, the current knowledge about the expression and regulation of IL-10R1 is still limited. Here we analyzed the expression of IL-10R1 on monocytic cells and demonstrated that human blood monocytes carried about 720 IL-10-binding sites on their surface. Compared with lymphocytes and various tissue cells and tissues, blood monocytes expressed the highest IL-10R1 levels. The in vitro differentiation of these cells into macrophages provoked a further increase of IL-10R1 surface expression. In contrast, their differentiation into myeloid dendritic cells (mDCs) resulted in reduced surface IL-10R1 levels. The different IL-10R1 levels expressed by monocyte-derived antigen-presenting cell populations were reflected in their different responsiveness toward IL-10. Importantly, also in vivo developed immature macrophages and mDCs showed different IL-10 sensitivity. These data suggest that, compared with monocytes and macrophages, mDCs partially escape from IL-10's inhibitory mechanisms by downregulating IL-10R1.Genes and Immunity advance online publication, 4 December 2014; doi:10.1038/gene.2014.69.

No comment yet.
Suggested by Société Francaise d'Immunologie
Scoop.it!

A Novel Mechanism of B Cell-Mediated Immune Suppression through CD73 Expression and Adenosine Production [IMMUNE REGULATION]

Immune suppression by regulatory T cells and regulatory B cells is a critical mechanism to limit excess inflammation and autoimmunity. IL-10 is considered the major mediator of B cell–induced immune suppression.
Gilbert C FAURE's insight:
Abstract

..... We report a novel mechanism for immune suppression through adenosine generation by B cells. We identified a novel population of B cells that expresses CD73 as well as CD39, two ectoenzymes that together catalyze the extracellular dephosphorylation of adenine nucleotides to adenosine. Whereas CD39 expression is common among B cells, CD73 expression is not. Approximately 30–50% of B-1 cells (B220+CD23−) and IL-10–producing B (B10) cells (B220+CD5+CD1dhi) are CD73hi, depending on mouse strain, whereas few conventional B-2 cells (B220+CD23+AA4.1−) express CD73. In keeping with expression of both CD73 and CD39, we found that CD73+ B cells produce adenosine in the presence of substrate, whereas B-2 cells do not. CD73−/− mice were more susceptible to dextran sulfate sodium salt (DSS)-induced colitis than wild type (WT) mice were, and transfer of CD73+ B cells ameliorated the severity of colitis, suggesting that B cell CD73/CD39/adenosine can modulate DSS-induced colitis. IL-10 production by B cells is not affected by CD73 deficiency. Interestingly, adenosine generation by IL-10−/− B cells is impaired because of reduced expression of CD73, indicating an unexpected connection between IL-10 and adenosine and suggesting caution in interpreting the results of studies with IL-10−/− cells.

No comment yet.
Scooped by Gilbert C FAURE
Scoop.it!

New gonorrhea treatment prevents reinfection - Salon

New gonorrhea treatment prevents reinfection - Salon | Immunology | Scoop.it
Salon
New gonorrhea treatment prevents reinfection
Salon
Russell observed high levels of a cytokine called interleukin-10 (IL-10) in gonococcal infections, and observed that it induces an innate immune response.
No comment yet.